Morgan Stanley’s Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share KLR.WS Stock Holding History

Morgan Stanley’s Portfolio KLR.WS Stock Details KLR.WS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-28,536	Closed	-$2.75K	–	8054
2023 Q3	$2.75K	Hold	28,536	–	–	﹤0.01%	7059
2023 Q2	$3.99K	Hold	28,536	–	–	﹤0.01%	7034
2023 Q1	$2.97K	Hold	28,536	–	–	﹤0.01%	7163
2022 Q4	$357	Hold	28,536	–	–	﹤0.01%	7594
2022 Q3	$3K	Buy	+28,536	New	+$6.47K	﹤0.01%	7424

Morgan Stanley's KLR.WS Position: Q4 2023 in Review

Morgan Stanley sold out of Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share (KLR.WS) in Q4 2023, closing a stake of 28,536 shares — an estimated $2.75K sold.

Morgan Stanley first reported a position in KLR.WS in Q3 2022 and held it in 5 quarters. The position peaked at $3.99K in Q2 2023. 0 funds tracked by Wall St. Rank hold KLR.WS as of Q4 2023.

Morgan Stanley reported no remaining Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share position as of Q4 2023 after selling out during the quarter.
Morgan Stanley sold 28,536 Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share shares in Q4 2023, an estimated $2.75K.
Morgan Stanley first reported a position in Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share in Q3 2022 and held it in 5 quarters.
Morgan Stanley's Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share position peaked at $3.99K in Q2 2023.
0 funds tracked by Wall St. Rank held Kaleyra, Inc. Warrants, each whole Warrant exercisable for one share of Common Stock at an exercise price of $40.25 per share as of Q4 2023.

Based on Morgan Stanley's 13F filing for Q4 2023, filed 13 Feb 2024.